Pharmacologic and clinical assessment of kratom.

  title={Pharmacologic and clinical assessment of kratom.},
  author={C. Michael White},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  volume={75 5},
  • C. White
  • Published 1 March 2018
  • Medicine, Biology
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
PURPOSE This article reviews the pharmacology, clinical utility, adverse effects, and abuse potential of kratom. SUMMARY The leaves of Mitragyna speciosa contain the biologically active alkaloids of kratom. Kratom exerts opioid and α-2 receptor agonistic effects as well as antiinflammatory and parasympathetic-impeding effects. There are no published human pharmacologic, pharmacokinetic, or drug interaction studies on kratom or mitragynine, making it virtually impossible to fully understand… 

Tables from this paper

Pharmacologic and clinical assessment of kratom: An update.
  • C. White
  • Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2019
Kratom has a unique pharmacologic profile that might offer advantages over other opioids, but its high abuse liability, potential for drug interactions and adverse events, and inadequate research into the balance of benefits to harm are concerning.
A Case of Kratom-induced Seizures
A case of kratom-induced tonic-clonic seizures in a 27-year-old Caucasian male with a psychiatric history of anxiety, attention-deficit/hyperactivity disorder, benzodiazepine use disorder, and opioid use disorder is reported, highlighting the life-threatening complications of Kratom that is easily available online.
Kratom: Implications for Health Care Providers.
Health care providers need to be familiar with the pharmacology, adverse effects, and problems associated with kratom ingestion when caring for individuals.
Understanding Kratom Use: A Guide for Healthcare Providers
A comprehensive overview of the available science on kratom is provided that has the potential to i clarity for healthcare providers and patients and makes recommendations for best practices in working with people who use kratom.
Drugs of Abuse and the Nervous System.
It is important for the practicing neurologist to possess awareness of the features and observed sequelae of the toxidromes of both traditional and nontraditional drugs of abuse because the use of both is widespread in the authors' society and conventional drug screening can miss detection of some powerful agents, thus forcing us to maintain a high index of suspicion based on recognition of the clinical features.
Pharmacotherapy for Management of 'Kratom Use Disorder': A Systematic Literature Review With Survey of Experts.
This first comprehensive review to examine the existing literature referring to management of KUD in combination with a survey of current experts' clinical consensus regarding pharmacological management finds it seems reasonable to extend the indication for MOUD to cases of moderate to severe KUD.
Kratom and General Anesthesia: A Case Report and Review of the Literature.
This is the first reported case of an anesthetic in a patient using kratom for chronic pain, and both the US Food and Drug Administration and the Drug Enforcement Agency warn against the use of kratom.
Kratom Adulterated with Phenylethylamine and Associated Intracerebral Hemorrhage: Linking Toxicologists and Public Health Officials to Identify Dangerous Adulterants
Medical toxicologists should form working relationships with laboratories and public health officials to aid in early identification of adulterated products that carry risk to the general population.
The Causes of Death and Pathological Findings of Kratom Users
The use of mitragynine may be a direct or indirect cause of death, whereas the lethal concentration has yet to be clearly determined.


Pharmacology of Kratom: An Emerging Botanical Agent With Stimulant, Analgesic and Opioid-Like Effects
Analyses of the medical literature and select Internet sites indicate that individuals in the United States are increasingly using kratom for the self-management of pain and opioid withdrawal.
Abuse potential and adverse cognitive effects of mitragynine (kratom)
Findings provide evidence for an addiction potential with cognitive impairments for mitragynine, which suggest its classification as a harmful drug.
Experiences of Kratom Users: A Qualitative Analysis
Abstract Kratom (Mitragyna speciosa) is a psychoactive plant that has been used since at least 1836 in folk medicine in Southeast Asian countries. More recently, kratom has become widely available in
From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.
CDC characterized kratom exposures that were reported to poison centers and uploaded to the National Poison Data System (NPDS) during January 2010-December 2015.
Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia
It is suggested that chronic kratom administration does not significantly impair social functioning of users in a natural context in Malaysia, despite being dependent on kratom for prolonged periods of time.
How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms
The desirable and adverse effects of MDMA are extensions of its fascinating pharmacologic and pharmacokinetic profile and are needed for education, prevention of harm, and treatment.
Seizure and Coma Following Kratom (Mitragynina speciosa Korth) Exposure
A rare case of Kratom toxicity characterized by a seizure and coma confirmed by urinary analysis of mitragynine by high performance liquid chromatography coupled to electrospray tandem mass spectrometry.
Opioid metabolism.